Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.

Outlook

Proposed suppression of the monograph on Tetrazepam (1738) from the Ph. Eur.: EDQM-2026- 04250-mail

Saatja [email protected] <[email protected]> Kuupäev T, 13.10.2026 11:41 Adressaat Signe Leito - RA <[email protected]>

Please make sure to include in any reply our mail reference: EDQM-2026-04250-mail ****************************************************************************

For the attention of NPAs Copy: Presidium Dear Colleagues,

Please find below the link to a survey being carried out concerning the proposed suppression of the monograph on Tetrazepam (1738) from the Ph. Eur. In order to have access to the survey, please copy and paste the following link into your Internet browser:

https://survey.edqm.eu/index.php?r=survey/index&sid=432725&lang=en

Deadline for replies: 9 November 2026. Thank you.

Kind regards, On behalf of Dr Sylvina Iossiphova

Andreea Mocoi Administrative Support Assistant European Pharmacopoeia Department European Directorate for the Quality of Medicines & HealthCare Council of Europe - Conseil de l'Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM To reach us, we invite you to contact us electronically. You can also contact us via HelpDesk https://www.edqm.eu / https://store.edqm.eu Stay connected with the EDQM

**************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2026-04250-mail